Synopsis of recent research by authors named "Zhou Jianmei"
- Zhou Jianmei’s recent research primarily focuses on the impact of comprehensive care in managing treatment-related side effects in cancer patients, specifically studying the benefits of such interventions on quality of life and psychological well-being in breast cancer patients undergoing capecitabine treatment.
- The author has also contributed to understanding genetic and molecular factors in cancers, exploring the prognostic potential of complement-related gene signatures in gastric cancer and implications of mRNA splicing in genetic diagnoses of conditions like Alport syndrome.
- Additionally, Zhang Jianmei's studies have investigated biomarkers related to kidney diseases in children, revealing significant correlations between urinary biomarkers and clinical outcomes, thus advocating for the integration of such biomarkers in monitoring glomerular diseases.